Scientists from around the world will be coming together at Neuroscience 2024 to share research, discover new ideas, and help move promising treatments forward. We look forward to being part of the conversation, and introducing a new service that’s launching soon.
Even more important, we’re eager to talk in more detail about your upcoming projects, and discuss ways that we can work together to advance your innovation quicker and with higher confidence.
Be on the lookout for these posters on recent neuroscience research conducted by our scientists:
-
Leveraging a hiPSC derived 3D tri-culture model to accelerate neuronal maturation and induce microglial dysfunction in a model of tauopathy
-
Evaluation of human induced pluripotent stem cell (hiPSC)-derived tri-culture as in vitro model for Alzheimer’s Disease
-
Development of robust iPSC-based α-synuclein, TAU and TDP-43 aggregation pathology in vitro models for drug discovery
-
A scalable platform, based on physiologically-relevant cellular models which can be leveraged for the high-throughput screening of drug candidates targeting pathological accumulation and aggregation of TAU, αSyn and TDP-43
We look forward to being part of the conversations in Chicago and hope to see you there!
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.
Lets chat about it at Neuroscience 2024.
|
Tim Keefe Senior Vice President, Business Development |
Schedule a meeting by filling out the form below:
Learn more about Neuroscience 2024 here.
|
|